(Q38412416)
Statements
1 reference
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer (English)
1 reference
Vienna Ludovini
1 reference
Fortunato Bianconi
1 reference
Lorenza Pistola
1 reference
Rita Chiari
1 reference
Vincenzo Minotti
1 reference
Renato Colella
1 reference
Dario Giuffrida
1 reference
Francesca Romana Tofanetti
1 reference
Annamaria Siggillino
1 reference
Antonella Flacco
1 reference
Elisa Baldelli
1 reference
Daniela Iacono
1 reference
Maria Grazia Mameli
1 reference
Antonio Cavaliere
1 reference
Lucio Crinò
1 reference
1 April 2011
1 reference
1 reference
Identifiers
1 reference